143 related articles for article (PubMed ID: 22393995)
1. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis.
Liu Y; Zhang D
Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995
[TBL] [Abstract][Full Text] [Related]
2. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
[TBL] [Abstract][Full Text] [Related]
4. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
6. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
7. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
[TBL] [Abstract][Full Text] [Related]
8. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
Yadav U; Kumar P; Rai V
Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis.
Guo S; Gao M; Li X; Li Y; Chu S; Zhu D; Niu W
PLoS One; 2012; 7(10):e47939. PubMed ID: 23110137
[TBL] [Abstract][Full Text] [Related]
11. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
13. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.
Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z
Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672
[TBL] [Abstract][Full Text] [Related]
14. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis.
Zhao HY; Gu Y; Yi YX
Tumour Biol; 2014 Mar; 35(3):2199-203. PubMed ID: 24142529
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.
Li C; Liu Y; Wei S; Zhou Y
Pediatr Blood Cancer; 2014 May; 61(5):771-7. PubMed ID: 24474393
[TBL] [Abstract][Full Text] [Related]
16. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.
Lajin B; Alachkar A
Br J Cancer; 2013 Sep; 109(5):1325-37. PubMed ID: 23860519
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with increased gastric cancer risk in Asians.
Zhang Y; Wang ZT; Zhong J
Genet Mol Res; 2012 Aug; 11(3):2328-37. PubMed ID: 22911602
[TBL] [Abstract][Full Text] [Related]
18. The NAD(P)H: quinine oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with gastric cancer risk: evidence from a case-control study and a meta-analysis.
Hu WG; Hu JJ; Cai W; Zheng MH; Zang L; Wang ZT; Zhu ZG
Asian Pac J Cancer Prev; 2014; 15(5):2363-7. PubMed ID: 24716985
[TBL] [Abstract][Full Text] [Related]
19. Association between NQO1 C609T polymorphism and prostate cancer risk.
Sun Z; Cui Y; Pei J; Fan Z
Tumour Biol; 2014 Aug; 35(8):7993-8. PubMed ID: 24838947
[TBL] [Abstract][Full Text] [Related]
20. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
